Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Cardiovascular therapeutics Market Research Reports

Titlepublishedprice

2022-2029 Global Angina Pectoris Treatment Professional Market Research Report, Analysis from Perspective of Segmentation (Competitor Landscape, Type, Application, and Geography)

By Maia Research
"...... vering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides detailed cost analysis, supply chain. Technological innovation and advancement will further......"
28-Apr-2022$2980

2022-2029 Global Transcatheter Mitral Valve Replacement Professional Market Research Report, Analysis from Perspective of Segmentation (Competitor Landscape, Type, Application, and Geography)

By Maia Research
"...... e, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides detailed cost analysis, supply chain. Technological innovation an......"
14-Apr-2022$2980

Arrhythmias Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

By Global Markets Direct
"...... e and Key Players, 2022 Update, provides an overview of the Arrhythmias (Cardiovascular) pipeline landscape. An arrhythmia is a problem with the rate or rhythm of the heartbeat. During an arrhythmia, the heart can beat too fast, too slow......"
31-Mar-2022$2000

Atrial Fibrillation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

By Global Markets Direct
"...... oA, Molecule Type and Key Players, 2022 Update, provides an overview of the Atrial Fibrillation (Cardiovascular) pipeline landscape. Atrial fibrillation is an irregular and often rapid heart rate that commonly causes poor blood flow to t......"
31-Mar-2022$2000

Congestive Heart Failure (Heart Failure) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

By Global Markets Direct
"...... by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Congestive Heart Failure (Cardiovascular) pipeline landscape. Heart failure is also known as congestive heart failure (CHF). CHF is a c......"
31-Mar-2022$2500

Myocardial Ischemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

By Global Markets Direct
"...... oA, Molecule Type and Key Players, 2022 Update, provides an overview of the Myocardial Ischemia (Cardiovascular) pipeline landscape. Lack of blood flow and oxygen to the heart muscle lead to cardiac ischemia, also called myocardial ische......"
31-Mar-2022$2000

Myocarditis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

By Global Markets Direct
"...... e and Key Players, 2022 Update, provides an overview of the Myocarditis (Cardiovascular) pipeline landscape. Myocarditis is inflammation of the heart muscle. Myocarditis is an uncommon disorder that is usually caused by viral, bacterial,......"
31-Mar-2022$2000

Restenosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

By Global Markets Direct
"...... and Key Players, 2022 Update, provides an overview of the Restenosis (Cardiovascular) pipeline landscape. Restenosis is re-narrowing of a blood vessel which leads to restricted blood flow. Symptoms include shortness of breath, difficulty......"
31-Mar-2022$2000

Pulmonary Embolism Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

By Global Markets Direct
"...... , Molecule Type and Key Players, 2022 Update, provides an overview of the Pulmonary Embolism (Cardiovascular) pipeline landscape. Pulmonary embolism is the sudden blockage of a major blood vessel (artery) in the lung, usually by a blood ......"
31-Mar-2022$2000

Global Coronary Artery Disease Therapeutics Market Status and Outlook 2022-2027

By Multimarket Insight
"...... the key information that requires from the clients. Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously lit......"
02-Mar-2022$3160

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy